None
SEDAR Interim Financial Statements

JNH · Price
[
{
"companyName": "Jack Nathan Medical Corp.",
"reportingPeriodEnd": "2025-10-31",
"reportStatus": "Unaudited",
"auditorName": null,
"auditorKeyMatters": [],
"balanceSheet": {
"cash": -188803,
"accountsAndOtherReceivables": 163176,
"governmentRemittancesReceivable": 169501,
"prepaidsAndDeposits": 77068,
"totalCurrentAssets": 220941,
"rightOfUseAssets": 175277,
"propertyAndEquipment": 130144,
"totalAssets": 526362,
"accountsPayableAndAccruedLiabilities": 1754032,
"governmentRemittancesPayable": 140178,
"leaseObligationCurrentPortion": 37933,
"totalCurrentLiabilities": 1932143,
"deferredRevenues": 473708,
"leaseObligation": 160785,
"totalLiabilities": 2566636,
"shareCapital": 19977634,
"contributedSurplus": 6601694,
"accumulatedOtherComprehensiveIncome": 0,
"deficit": -28619601,
"shareholdersDeficit": -2040273,
"cashPerShare": -0.0022,
"workingCapitalPerShare": -0.0196
},
"incomeStatement": {
"revenues": 504291,
"associateFees": 46049,
"clinicOperations": 468491,
"clinicSupplies": 195696,
"licenseFees": 39796,
"consultingFees": 107065,
"professionalFees": 263159,
"investorCommunications": 31833,
"officeAndGeneral": 220122,
"advertisingAndPromotion": 163102,
"acquisitionRelatedCost": 0,
"salariesAndWages": 388715,
"shareBasedCompensationExpense": 0,
"badDebtExpenseRecovery": 0,
"depreciationAndAmortization": 76225,
"totalOperatingExpenses": 2000253,
"lossFromOperations": -1495962,
"interestIncome": 5316.85,
"financeCosts": 22387,
"foreignExchangeGainLoss": -1241,
"otherIncomeExpense": -1602848,
"lossBeforeTaxes": -3072348,
"currentIncomeTaxRecoveryExpense": 0,
"netLoss": -3072348,
"foreignCurrencyTranslationAdjustment": 0,
"comprehensiveLoss": -3072348,
"lossPerShareBasic": -0.04,
"lossPerShareDiluted": -0.04,
"weightedAverageSharesOutstandingBasic": 87099159,
"weightedAverageSharesOutstandingDiluted": 96101665
},
"cashFlowStatement": {
"lossBeforeTaxes": -3072348,
"shareBasedCompensationExpense": 0,
"depreciation": 50712,
"depreciationRightOfUseAssets": 57914,
"amortizationIntangibleAssets": 0,
"amortizationDebtIssuanceCost": 0,
"discountOnDebenture": 0,
"interestExpenseOnLeaseObligation": 23065,
"cebaLoanForgiveness": 0,
"profitOnSaleOfPropertyAndEquipment": 0,
"lossOnCancellationOfLease": 0,
"accretionExpense": -678.01,
"changesInNonCashWorkingCapital": {
"accountsAndOtherReceivables": -148903,
"governmentRemittancesReceivablePayable": 849094,
"prepaidsAndDeposits": -102068,
"inventory": 0,
"otherReceivable": 0,
"accountsPayableAndAccruedLiabilities": 1955726,
"tenantsDeposits": 238119.86,
"deferredRevenue": 891514,
"deferredTaxLiabilities": 0
},
"cashUsedInOperatingActivities": 742149,
"purchaseOfPropertyAndEquipment": -1400,
"constructionInProgress": 0,
"proceedsOnSaleOfPropertyAndEquipment": 0,
"cashUsedInInvestingActivities": -1400,
"proceedsOfLoansPayable": 0,
"repaymentOfLoansPayable": 0,
"repaymentOfLeaseObligations": -67661,
"fundsReceivedForConstructionInProgress": 0,
"cashGainedFromFinancingActivities": -67660.71,
"effectOfForeignCurrencyTranslation": 0,
"netDecreaseIncreaseInCash": 742149,
"cashBeginningOfPeriod": 327119,
"cashEndOfPeriod": 1069268
},
"investmentsAndOtherAssets": [],
"shareStructure": {
"authorizedShares": "Unlimited",
"issuedShares": 87099159,
"classesOfShares": ["common"],
"warrants": [],
"options": [
{
"number": 500000,
"exercisePrice": 0.05,
"expiryDate": "2026-08-31"
},
{
"number": 500000,
"exercisePrice": 0.05,
"expiryDate": "2027-08-31"
},
{
"number": 500000,
"exercisePrice": 0.05,
"expiryDate": "2029-08-31"
}
],
"rightsConvertibleInstruments": null
},
"managementCompensation": {
"currency": "CAD",
"periods": {
"nine months ended October 31, 2025": {
"salariesAndConsultingFees": 230000,
"directorFees": 19859951
}
},
"namedIndividuals": [],
"otherRelatedPartyTransactions": [
{
"counterparty": "directors",
"description": "fees",
"amount": 19859951,
"period": "nine months ended October 31, 2025"
}
]
},
"subsequentEvents": []
}
]
More from Jack Nathan Medical Corp
Jan 23, 2026 · 18:57